Attention AACR Annual Meeting 2017 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 61 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 58 59 60 61 presentations: 1 to 25 of 1509
Gene dysregulation in cancer: The view from chromosome neighborhoods
Richard A. Young
MIT Whitehead Inst. for Biomed. Research, Cambridge, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Histone modifications and gene expression in cancer
Scott A. Armstrong
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
ATP-dependent chromatin remodeling complexes in human cancer
Cigall Kadoch
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Enhancer reprogramming during cancer progression
Christopher R. Vakoc
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Novel protein reagents for target validation and studying cancer signaling pathways
Darren C Tomlinson
Cancer Research UK, Leeds, United Kingdom
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
The Affimer technology platform: A novel scaffold for cancer biotherapeutics
Amrik Basran
Avacta Life Sciences, Cambridge, United Kingdom
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Phenotypic screens for developmental modulators in zebrafish: A rich ore to mine for future cancer therapeutics
Charles C Hong
Vanderbilt University School of Medicine, Nashville, TN, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Challenges in application of quantitative high-content pharmacodynamic extraction assays for MET activation
Apurva K Srivastava
SAIC-Frederick, Frederick, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
PD analysis of MET signaling in fixed tissue specimens by quantitative multiplex immunofluorescence and concordance with extraction assays
Tony Navas
NCI-Frederick/Leidos Biomed. Research, Inc., Frederick, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Summary
Robert J. Kinders
Frederick National Laboratory, Frederick, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Somatic HLA mutations and neoantigen identification for immunotherapy analyses
Sachet A Shukla
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Dynamics of genomic and neoantigen landscape during immune checkpoint blockade
Valsamo Anagnostou
Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Integrative clinical and genomic analysis of solid tumors treated with immune checkpoint blockade
Jeffrey E Hammerbacher
Icahn School Of Medicine At Mount Sinai, New York, NY, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Infiltrating immune cell signatures and genomic determinants of immune recognition in diverse tumors
Ash A. Alizadeh
Stanford Univ., Stanford, CA, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Introduction
Cornelia Liu Trimble
Johns Hopkins Univ., Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 3:15 PM-5:15 PM
High-dimensional immune monitoring of tumor tissues for cancer immunotherapy
Sacha Gnjatic
Icahn School of Medicine at Mount Sinai, New York, NY, United States
from AACR Annual Meeting 2017 on April 1, 2017 3:15 PM-5:15 PM
Targeting pathogen-induced malignancies: Lessons learned from adoptive T cell transfer for merkel cell carcinoma
Aude G. Chapuis
Fred Hutchinson Cancer Research Ctr., Seattle, WA, United States
from AACR Annual Meeting 2017 on April 1, 2017 3:15 PM-5:15 PM
Developing a biomarker platform to serve targeted therapy and immunotherapy
Keith T Flaherty
Massachusetts General Hosp. Cancer Ctr., Boston, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 3:15 PM-5:15 PM
High-dimensional analyses of the mucosal microenvironment in precancerous, intraepithelial cervical HPV disease
Cornelia L. Trimble
Johns Hopkins Univ., Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 3:15 PM-5:15 PM
Invited Speaker
Karen H. Vousden
Beatson Inst. for Cancer Research, Glasgow, United Kingdom
from AACR Annual Meeting 2017 on April 2, 2017 7:00 AM-8:00 AM
Invited Speaker
Ronny I. Drapkin
University of Pennsylvania, Philadelphia, PA, United States
from AACR Annual Meeting 2017 on April 2, 2017 7:00 AM-8:00 AM
Invited Speaker
Daniel S. Chen
Genentech, Inc., South San Francisco, CA, United States
from AACR Annual Meeting 2017 on April 2, 2017 7:00 AM-8:00 AM
Invited Speaker
Norman E. Sharpless
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, United States
from AACR Annual Meeting 2017 on April 2, 2017 7:00 AM-8:00 AM
Invited Speaker
Barry S. Taylor
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2017 on April 2, 2017 7:00 AM-8:00 AM
Invited Speaker
Sara A. Courtneidge
Oregon Health & Science Univ., Portland, OR, United States
from AACR Annual Meeting 2017 on April 2, 2017 7:00 AM-8:00 AM
<< first | < prev page: of 61 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 58 59 60 61 presentations: 1 to 25 of 1509